Literature DB >> 29940136

The association between physician trust and prostate-specific antigen screening: Implications for shared decision-making.

Zachary Klaassen1, Christopher J D Wallis1, Hanan Goldberg1, Thenappan Chandrasekar1, Neil E Fleshner1, Antonio Finelli1, Girish S Kulkarni1, Allan S Detsky1, Raj Satkunasivam1.   

Abstract

INTRODUCTION: Shared decision-making is widely recommended when men are considering prostate cancer screening with prostate-specific antigen (PSA). The role of patients' trust in cancer information from their physician in such decisions is unknown.
METHODS: We identified male respondents ≥18 years of age from the Health Information National Trends Survey, a population-based survey of people living in the U.S. (2011-014). We assessed the association between degree of trust in cancer information from respondent's physician with patient-reported receipt of PSA-screening and patient-reported discussion of PSA screening with their physician.
RESULTS: Among 5069 eligible respondents, 3606 (71.1%) men reported trusting cancer information from their physician "a lot," 1186 (23.4%) "somewhat," 219 (4.3%) "a little," and 58 (1.1%) "not at all." A total of 2655 (52.4%) men reported receiving PSA screening. The degree of trust an individual had in his physician for cancer information was strongly associated with his likelihood of having received PSA screening (ptrend<0.0001) (54.9% "a lot" vs. 27.6% "not at all"). These findings persisted after multivariable regression. Similarly, men who had high levels of trust in their physician were more likely to have discussed PSA screening with a strong trend across strata (ptrend<0.0001).
CONCLUSIONS: The level of trust an individual has in cancer information from his physician is strongly associated with his likelihood of discussing and undergoing PSA screening. As rationale, implementation of PSA screening requires shared decision-making, and the level of trust an individual has in his physician has important implications for dissemination of PSA screening guidelines.

Entities:  

Year:  2018        PMID: 29940136      PMCID: PMC6261724          DOI: 10.5489/cuaj.5351

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  16 in total

1.  Early detection of prostate cancer: AUA Guideline.

Authors:  H Ballentine Carter; Peter C Albertsen; Michael J Barry; Ruth Etzioni; Stephen J Freedland; Kirsten Lynn Greene; Lars Holmberg; Philip Kantoff; Badrinath R Konety; Mohammad Hassan Murad; David F Penson; Anthony L Zietman
Journal:  J Urol       Date:  2013-05-06       Impact factor: 7.450

2.  Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2012-07-17       Impact factor: 25.391

3.  Patient trust in physicians and shared decision-making among African-Americans with diabetes.

Authors:  Monica E Peek; Rita Gorawara-Bhat; Michael T Quinn; Angela Odoms-Young; Shannon C Wilson; Marshall H Chin
Journal:  Health Commun       Date:  2012-10-10

4.  An ultra-brief screening scale for anxiety and depression: the PHQ-4.

Authors:  Kurt Kroenke; Robert L Spitzer; Janet B W Williams; Bernd Löwe
Journal:  Psychosomatics       Date:  2009 Nov-Dec       Impact factor: 2.386

5.  Getting Black Men to Undergo Prostate Cancer Screening: The Role of Social Capital.

Authors:  Lorraine T Dean; S V Subramanian; David R Williams; Katrina Armstrong; Camille Zubrinsky Charles; Ichiro Kawachi
Journal:  Am J Mens Health       Date:  2014-08-12

6.  Association of sociodemographic factors and prostate-specific antigen (PSA) testing.

Authors:  William Gorday; Hossein Sadrzadeh; Lawrence de Koning; Christopher Naugler
Journal:  Clin Biochem       Date:  2014-08-14       Impact factor: 3.281

7.  Prostate cancer screening and informed decision-making: provider and patient perspectives.

Authors:  D J Bowen; P A Hannon; J R Harris; D P Martin
Journal:  Prostate Cancer Prostatic Dis       Date:  2011-01-18       Impact factor: 5.554

8.  A preliminary evaluation of trust and shared decision making among intensive care patients' family members.

Authors:  Elizabeth G Epstein; Katherine Wolfe
Journal:  Appl Nurs Res       Date:  2016-08-31       Impact factor: 2.257

9.  An examination of variations in the uptake of prostate cancer screening within and between the countries of the EU-27.

Authors:  Richeal Burns; Brendan Walsh; Stephen O'Neill; Ciaran O'Neill
Journal:  Health Policy       Date:  2012-09-06       Impact factor: 2.980

10.  How does trust affect patient preferences for participation in decision-making?

Authors:  Nancy Kraetschmer; Natasha Sharpe; Sara Urowitz; Raisa B Deber
Journal:  Health Expect       Date:  2004-12       Impact factor: 3.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.